Connection

Chih-Cheng Lai to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Chih-Cheng Lai has written about Randomized Controlled Trials as Topic.
Chih-Cheng Lai
Connection Strength
0.267
Randomized Controlled Trials as Topic
  1. Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. Int Immunopharmacol. 2021 Oct; 99:108027.
    View in: PubMed
    Score: 0.058
  2. Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2021 07 15; 76(8):1962-1968.
    View in: PubMed
    Score: 0.058
  3. COVID-19 vaccines: concerns beyond protective efficacy and safety. Expert Rev Vaccines. 2021 08; 20(8):1013-1025.
    View in: PubMed
    Score: 0.058
  4. Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. J Microbiol Immunol Infect. 2021 Oct; 54(5):767-775.
    View in: PubMed
    Score: 0.058
  5. Current challenges in the management of invasive fungal infections. J Infect Chemother. 2008 Apr; 14(2):77-85.
    View in: PubMed
    Score: 0.023
  6. Echinocandins vs. amphotericin B against invasive candidiasis in children and neonates: A meta-analysis of randomized controlled trials. Int J Antimicrob Agents. 2019 Jun; 53(6):789-794.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.